FDA Import Refusal AEK-0899186-0/20002/1 — Daewoong Pharmaceutical
The FDA refused shipment AEK-0899186-0/20002/1 from Daewoong Pharmaceutical (South Korea) on Aug 14, 2026. The refused product falls under Drugs and Biologics — ONABOTULINUMTOXINA. Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Aug 14, 2026
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 58PCZ05 ONABOTULINUMTOXINA
- Charges
- 75